<DOC>
	<DOCNO>NCT01398644</DOCNO>
	<brief_summary>Hereditary hemochromatosis ( HH ) genetic disorder iron metabolism , result excessive iron overload . Phlebotomy currently standard therapy . More recently Therapeutic Erythrocytapheresis ( TE ) become new therapeutic modality , potentially offer efficient method remove iron overload few procedures.In propose clinical trial investigator examine whether TE keep ferritin level patient require maintenance therapy 50 microg/L , minimally half number treatment procedure compare current standard therapy P .</brief_summary>
	<brief_title>Erythrocytapheresis Versus Phlebotomy Maintenance Therapy Hereditary Hemochromatosis ( HH ) Patients</brief_title>
	<detailed_description>The research population exist patient HH ( genetic analysis confirm homozygous C282Y ) live south-east Netherlands currently treat phlebotomy maintenance treatment keep serum ferritin level &lt; 50 ug/l . Ferritin level start inclusion 30-50ug/l . Exclusion criterion : patient receive therapy chelate therapy force dietary regimen , patient excessive overweight ( BMI &gt; 35 ) . After enrollment patient randomize start either TE continue P. After year treatment serum ferritin level &lt; 50ug/l , patient continue study treat two treatment . Randomization do block randomization .</detailed_description>
	<mesh_term>Hemochromatosis</mesh_term>
	<criteria>homozygous C282Y currently treat phlebotomy maintenance therapy least 6 month ferritin level 3050 micog/L age 18 year old weight 50 kg sign informed consent willingness fill additional questionnaire three point time chelate therapy force dietary regime age 18 year excessive overweight ( BMI 35 ) pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Phlebotomy</keyword>
	<keyword>Therapeutic erythrocytapheresis</keyword>
	<keyword>Hereditary Hemochromatosis</keyword>
	<keyword>maintenance therapy</keyword>
</DOC>